Devonian Health Group Inc
Research Devonian Health Group Inc (GSD) on Bullrun: market cap CAD 22.25M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerGSD
- ExchangeV
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCAD
- Market capCAD 22.25M
- Financial periodQ2 2026
- RevenueCAD 176.64K
- Net income-CAD 1.94M
- Free cash flow-CAD 732.11K
- Gross margin111.3%
Valuation Snapshot
latest market cap is CAD 22.25M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 18.52M | -CAD 6.97M | -CAD 6.22M | 38.4% | n/a | CAD 6.64M | CAD 114.22K | CAD 9.60M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-14 | CAD 22.25M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CAD.
About Devonian Health Group Inc
Devonian Health Group Inc. operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally. It engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Devonian Health Group Inc's market cap?
Devonian Health Group Inc's market capitalization is CAD 22.25M.
What does Devonian Health Group Inc do?
Devonian Health Group Inc. operates as a clinical stage biopharmaceutical corporation with novel therapeutic approaches targeting unmet medical needs in Canada and Internationally. It engages in the development of botanical drugs.